Estimated absolute event rate differences and NNH associated with 1 year of monthly IVIg infusions for each TEE end point
| Outcome . | One-year cumulative incidence in unexposed . | HR associated with days 0-30 after IVIg (95% CI) . | Risk difference (95% CI) associated with 1 year of treatment . | NNH (95% CI) associated with 1 year of treatment . |
|---|---|---|---|---|
| Arterial TEE (AMI or ischemic stroke) | 1.8% | 1.38 (0.89, 2.14) | 0.7% (-0.2%, 2.0%) | 150 (50, ∞) |
| Venous TEE (DVT or PE) | 1.1% | 1.27 (0.67, 2.41) | 0.3% (-0.4%, 1.5%) | 340 (66, ∞) |
| Composite end point (arterial or venous TEE) | 2.9% | 1.36 (0.95, 1.96) | 1.0% (-0.2%, 2.7%) | 98 (37, ∞) |
| Outcome . | One-year cumulative incidence in unexposed . | HR associated with days 0-30 after IVIg (95% CI) . | Risk difference (95% CI) associated with 1 year of treatment . | NNH (95% CI) associated with 1 year of treatment . |
|---|---|---|---|---|
| Arterial TEE (AMI or ischemic stroke) | 1.8% | 1.38 (0.89, 2.14) | 0.7% (-0.2%, 2.0%) | 150 (50, ∞) |
| Venous TEE (DVT or PE) | 1.1% | 1.27 (0.67, 2.41) | 0.3% (-0.4%, 1.5%) | 340 (66, ∞) |
| Composite end point (arterial or venous TEE) | 2.9% | 1.36 (0.95, 1.96) | 1.0% (-0.2%, 2.7%) | 98 (37, ∞) |